Inventor
ALLERSON CHARLES
US21 patents
⚠️ This page may combine multiple inventors who share the name “ALLERSON CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
6 patentsUS9005906B2Apr 14, 2015
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC163 citations99
US7696345B2Apr 13, 2010
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
ISIS PHARMACEUTICALS INC426 citations99
US8796437B2Aug 5, 2014
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC85 citations98
US7939677B2May 10, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC152 citations98
US7875733B2Jan 25, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC159 citations98
US7569686B1Aug 4, 2009
Compounds and methods for synthesis of bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC501 citations98
ALLERSON CHARLES
5 patentsUS8124745B2Feb 28, 2012
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
ALLERSON CHARLES203 citations98
US8604183B2Dec 10, 2013
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
ALLERSON CHARLES20 citations92
US9150606B2Oct 6, 2015
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
ALLERSON CHARLES9 citations84
US9150605B2Oct 6, 2015
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
ALLERSON CHARLES9 citations84
US8779118B2Jul 15, 2014
Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
ALLERSON CHARLES14 citations84
IONIS PHARMACEUTICALS INC
3 patentsUS10266825B2Apr 23, 2019
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
IONIS PHARMACEUTICALS INC10 citations84
US9708610B2Jul 18, 2017
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
IONIS PHARMACEUTICALS INC6 citations82
US11078485B2Aug 3, 2021
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
IONIS PHARMACEUTICALS INC0 citations62